-
1.发明授权Sulfonamide substituted pyrazoline compounds, their preparation and use as CB1 modulators 失效磺酰胺取代的吡唑啉化合物，其制备和用作CB1调节剂公开(公告)号：US08044053B2
公开(公告)日：2011-10-25
申请号：US12445260
申请日：2007-10-10
IPC分类号： A61K31/501 , A61K31/496 , A61K31/497 , A61K31/437 , A61K31/4523 , A61K31/415 , A61K31/4178 , A61K31/4245 , A61K31/426 , A61K31/433 , C07D237/02 , C07D239/02 , C07D241/02 , C07D221/02 , C07D221/00 , C07D401/02 , C07D277/20 , C07D263/30 , C07D271/08 , C07D285/10 , C07D233/54 , C07D231/10
CPC分类号： C07D231/06 , C07D401/12 , C07D403/12 , C07D405/12 , C07D409/12 , C07D413/12 , C07D417/12 , C07D513/04
摘要： The present invention relates to substituted pyrazoline compounds of general formula (I), methods for their preparation, medicaments comprising these compounds as well as their use for the preparation of a medicament for the treatment of humans and animals.
摘要翻译： 本发明涉及通式（I）的取代吡唑啉化合物，其制备方法，包含这些化合物的药物及其制备用于治疗人和动物的药物的用途。
-
2.发明申请SULFONAMIDE SUBSTITUTED PYRAZOLINE COMPOUNDS, THEIR PREPARATION AND USE AS CB1 MODULATORS 失效磺酰胺取代的吡咯啉化合物，其制备和用作CB1调节剂公开(公告)号：US20100184772A1
公开(公告)日：2010-07-22
申请号：US12445260
申请日：2007-10-10
IPC分类号： C07D231/06 , A61K31/415 , A61K31/4178 , C07D403/12 , C07D409/12 , A61K31/4155 , A61K31/428 , C07D417/12 , C07D405/12 , C07D413/12 , A61K31/422 , A61K31/513 , C07D401/12 , A61K31/4709 , A61K31/4439 , A61K31/4245 , A61K31/433 , A61K31/427 , A61K31/4725 , A61K31/498 , C07D513/04 , A61K31/429 , A61P5/00 , A61P9/00 , A61P11/00 , A61P25/00 , A61P37/00 , A61P15/00 , A61P1/00 , A61P35/00 , A61P19/00 , A61P3/00
CPC分类号： C07D231/06 , C07D401/12 , C07D403/12 , C07D405/12 , C07D409/12 , C07D413/12 , C07D417/12 , C07D513/04
摘要： The present invention relates to substituted pyrazoline compounds of general formula (I), methods for their preparation, medicaments comprising these compounds as well as their use for the preparation of a medicament for the treatment of humans and animals.
摘要翻译： 本发明涉及通式（I）的取代吡唑啉化合物，其制备方法，包含这些化合物的药物及其制备用于治疗人和动物的药物的用途。
-
搜索结果
2 条记录 (耗时 0.015 秒)
